Eugène L. Giroux

1.5k total citations
44 papers, 1.3k citations indexed

About

Eugène L. Giroux is a scholar working on Molecular Biology, Nutrition and Dietetics and Oncology. According to data from OpenAlex, Eugène L. Giroux has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Nutrition and Dietetics and 12 papers in Oncology. Recurrent topics in Eugène L. Giroux's work include Trace Elements in Health (14 papers), Drug Transport and Resistance Mechanisms (7 papers) and Biochemical and Molecular Research (5 papers). Eugène L. Giroux is often cited by papers focused on Trace Elements in Health (14 papers), Drug Transport and Resistance Mechanisms (7 papers) and Biochemical and Molecular Research (5 papers). Eugène L. Giroux collaborates with scholars based in United States, France and Canada. Eugène L. Giroux's co-authors include Henkin Ri, Paul J. Schechter, Josiane Schoun, Leland M. Vane, Gary A. Flynn, Richard C. Dage, Robert I. Henkin, Evan R. Kantrowitz, Albert Sjoerdsma and Franklin R. Alvarez and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

Eugène L. Giroux

44 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugène L. Giroux United States 19 471 424 216 203 176 44 1.3k
D. A. Rowley United Kingdom 13 391 0.8× 408 1.0× 78 0.4× 236 1.2× 151 0.9× 16 1.6k
Sara E. Bryan United States 19 316 0.7× 270 0.6× 153 0.7× 81 0.4× 270 1.5× 32 1.1k
David A. Rowley United States 13 167 0.4× 318 0.8× 141 0.7× 199 1.0× 74 0.4× 19 1.0k
Hiroshi Kozuka Japan 25 443 0.9× 858 2.0× 131 0.6× 146 0.7× 469 2.7× 157 2.0k
Phillip M. Hanna United States 19 286 0.6× 359 0.8× 111 0.5× 232 1.1× 173 1.0× 23 1.4k
Edward Sanders United States 23 127 0.3× 433 1.0× 131 0.6× 165 0.8× 105 0.6× 53 1.5k
Glenn F. Vile New Zealand 19 202 0.4× 1.1k 2.5× 97 0.4× 169 0.8× 139 0.8× 23 1.9k
Jan Kovář Czechia 27 221 0.5× 1.1k 2.5× 378 1.8× 279 1.4× 86 0.5× 160 2.3k
Vicente Rodilla Spain 17 316 0.7× 384 0.9× 92 0.4× 78 0.4× 287 1.6× 48 1.3k
Ernst S. Henle United States 10 165 0.4× 843 2.0× 129 0.6× 112 0.6× 77 0.4× 11 1.4k

Countries citing papers authored by Eugène L. Giroux

Since Specialization
Citations

This map shows the geographic impact of Eugène L. Giroux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugène L. Giroux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugène L. Giroux more than expected).

Fields of papers citing papers by Eugène L. Giroux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugène L. Giroux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugène L. Giroux. The network helps show where Eugène L. Giroux may publish in the future.

Co-authorship network of co-authors of Eugène L. Giroux

This figure shows the co-authorship network connecting the top 25 collaborators of Eugène L. Giroux. A scholar is included among the top collaborators of Eugène L. Giroux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugène L. Giroux. Eugène L. Giroux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giroux, Eugène L., et al.. (2023). Aptamer-, heparin- or cocktail-based inhibition of S1-ACE2 protein complexes. Analytical Biochemistry. 676. 115223–115223. 3 indexed citations
2.
Vane, Leland M., Franklin R. Alvarez, & Eugène L. Giroux. (1999). Reduction of concentration polarization in pervaporation using vibrating membrane module. Journal of Membrane Science. 153(2). 233–241. 40 indexed citations
3.
Caperelli, Carol A. & Eugène L. Giroux. (1997). The Human Glycinamide Ribonucleotide Transformylase Domain: Purification, Characterization, and Kinetic Mechanism. Archives of Biochemistry and Biophysics. 341(1). 98–103. 17 indexed citations
4.
Giroux, Eugène L., et al.. (1997). Importance of the Dimer-Dimer Interface for Allosteric Signal Transduction and AMP Cooperativity of Pig Kidney Fructose-1,6-Bisphosphatase. Journal of Biological Chemistry. 272(8). 5076–5081. 16 indexed citations
5.
Stec, Boguslaw, Reimar Abraham, Eugène L. Giroux, & Evan R. Kantrowitz. (1996). Crystal structures of the active site mutant (Arg‐243 → Ala) in the T and R allosteric states of pig kidney fructose‐1,6‐bisphosphatase expressed in escherichia coli. Protein Science. 5(8). 1541–1553. 7 indexed citations
7.
Giroux, Eugène L., et al.. (1996). Glutamic Acid Residue 98 Is Critical for Catalysis in Pig Kidney Fructose-1,6-bisphosphatase. Biochemical and Biophysical Research Communications. 219(3). 848–852. 16 indexed citations
8.
Giroux, Eugène L., Malik Williams, & Evan R. Kantrowitz. (1994). Shared active sites of fructose-1,6-bisphosphatase. Arginine 243 mediates substrate binding and fructose 2,6-bisphosphate inhibition.. Journal of Biological Chemistry. 269(50). 31404–31409. 17 indexed citations
9.
Burkholder, Timothy P., et al.. (1992). Acid-catalyzed O-allylation of β-hydroxy-α-amino acids: an entry into conformationally constrained dipeptide surrogates. Bioorganic & Medicinal Chemistry Letters. 2(6). 579–582. 4 indexed citations
10.
Giroux, Eugène L.. (1991). Fitting Progress Curves in Assays of Slow-Binding Enzyme Inhibitors. Journal of enzyme inhibition. 5(3). 249–257. 1 indexed citations
11.
Peet, Norton P., Joseph P. Burkhart, Michael R. Angelastro, et al.. (1990). Synthesis of peptidyl fluoromethyl ketones and peptidyl .alpha.-keto esters as inhibitors of porcine pancreatic elastase, human neutrophil elastase, and rat and human neutrophil cathepsin G. Journal of Medicinal Chemistry. 33(1). 394–407. 103 indexed citations
12.
Giroux, Eugène L., Douglas W. Beight, Richard C. Dage, & Gary A. Flynn. (1989). Interaction of Angiotensin I-Converting Enzyme with Two Potent Tricyclic Inhibitors. Journal of enzyme inhibition. 2(4). 269–277. 4 indexed citations
13.
Giroux, Eugène L., et al.. (1983). Tissue-and metal-specific effects of thiolacrylic acids in rats. Biological Trace Element Research. 5(2). 115–128. 4 indexed citations
14.
Petering, Harold G., et al.. (1982). Consecutive zinc balance trials in growing rats. Biological Trace Element Research. 4(2-3). 221–232. 7 indexed citations
15.
Giroux, Eugène L., et al.. (1978). Induction by a-Mercapto-β-arylacrylic Acids of Low-molecular-weight Zinc-binding Protein in Rat Liver. Bioinorganic Chemistry. 9(3). 205–216. 3 indexed citations
16.
Schoun, Josiane, et al.. (1977). Metal complexation by α-mercapto- β-aryl acrylic acids. Canadian Journal of Chemistry. 55(23). 4028–4036. 22 indexed citations
17.
Giroux, Eugène L., et al.. (1977). Influence of Zinc-Ligand Mixtures on Serum Zinc Levels in Rats. Journal of Pharmaceutical Sciences. 66(3). 391–395. 33 indexed citations
18.
Giroux, Eugène L., Paul J. Schechter, Josiane Schoun, & Albert Sjoerdsma. (1977). Reduced binding of added zinc in serum of patients with decompensated hepatic cirrhosis. European Journal of Clinical Investigation. 7(1). 71–73. 34 indexed citations
19.
Vargaftig, B. Boris, Jean Lefort, & Eugène L. Giroux. (1976). Haemorrhagic and inflammatory properties of collagenase fromC. histolyticum. Inflammation Research. 6(5). 627–635. 12 indexed citations
20.
Giroux, Eugène L. & R.I. Henkin. (1971). Oral effects of hydrolytic enzymes on taste acuity in man. Life Sciences. 10(7). 361–370. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026